Previous studies reported that high LOX expression is associated with poor survival of triple-negative breast cancer, and silencing LOX can induce breast cancer cell apoptosis and reduce its chemotherapy resistance (4). This evidence concerns the gene LOX and triple-negative breast carcinoma.